Polymer Factory (POLYMER) Q1 2026 earnings summary

Executive summary

• Q1 2026 saw decreased net sales and increased losses amid continued market uncertainty and cautious customer behavior.

• Directed share issues raised SEK 2.28 million to strengthen working capital.

• Participation in major industry events and collaborations with academic and industrial partners continued.

• Dendritic polymers demonstrated strong antimicrobial performance in advanced fiber membranes.

Financial highlights

• Net sales for Q1 2026 were SEK 303k, down 13% year-over-year from SEK 348k.

• Loss for the period increased to SEK -1,345k from SEK -880k in Q1 2025.

• Cash flow for the period was SEK 563k, up from SEK 346k in Q1 2025, mainly due to financing activities.

• Equity/assets ratio improved to 83% from 64% year-over-year.

• Earnings per share remained at SEK -0.08, unchanged from Q1 2025.

Outlook and guidance

• Focus remains on strengthening market position and developing advanced nanomaterials.

• Board notes risk of insufficient financing over the next 12 months if sales do not improve or further capital is not raised.